Virtus ETF Advisers LLC Acadia Pharmaceuticals Inc Transaction History

Virtus ETF Advisers LLC

  • $196 Million
  • Q2 2024

A detailed history of Virtus ETF Advisers LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 21,826 shares of ACAD stock, worth $322,806. This represents 0.18% of its overall portfolio holdings.

Number of Shares
21,826
Previous 13,579 60.73%
Holding current value
$322,806
Previous $251,000 41.04%
% of portfolio
0.18%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$14.62 - $18.42 $120,571 - $151,909
8,247 Added 60.73%
21,826 $354,000
Q1 2024

May 15, 2024
BUY
$17.79 - $30.86 $34,761 - $60,300
1,954 Added 16.81%
13,579 $251,000
Q4 2023

Feb 15, 2024
SELL
$20.78 - $31.77 $20,364 - $31,134
-980 Reduced 7.77%
11,625 $363,000
Q3 2023

Nov 07, 2023
SELL
$20.84 - $33.47 $33,969 - $54,556
-1,630 Reduced 11.45%
12,605 $262,000
Q2 2023

Aug 14, 2023
SELL
$17.8 - $25.65 $94,073 - $135,560
-5,285 Reduced 27.07%
14,235 $340,000
Q1 2023

May 15, 2023
BUY
$16.32 - $20.92 $5,663 - $7,259
347 Added 1.81%
19,520 $367,000
Q4 2022

Feb 14, 2023
BUY
$14.2 - $18.63 $66,456 - $87,188
4,680 Added 32.29%
19,173 $305,000
Q3 2022

Nov 14, 2022
BUY
$14.11 - $18.27 $3,005 - $3,891
213 Added 1.49%
14,493 $237,000
Q2 2022

Aug 12, 2022
SELL
$13.01 - $27.22 $24,614 - $51,500
-1,892 Reduced 11.7%
14,280 $201,000
Q4 2021

Feb 14, 2022
SELL
$16.79 - $27.09 $10,292 - $16,606
-613 Reduced 3.65%
16,172 $377,000
Q3 2021

Nov 15, 2021
SELL
$15.78 - $24.77 $24,380 - $38,269
-1,545 Reduced 8.43%
16,785 $279,000
Q2 2021

Aug 10, 2021
BUY
$19.4 - $27.42 $122,724 - $173,458
6,326 Added 52.7%
18,330 $447,000
Q1 2021

May 17, 2021
BUY
$25.02 - $54.99 $8,231 - $18,091
329 Added 2.82%
12,004 $310,000
Q4 2020

Feb 12, 2021
SELL
$41.04 - $56.79 $44,035 - $60,935
-1,073 Reduced 8.42%
11,675 $624,000
Q3 2020

Nov 13, 2020
BUY
$36.42 - $57.0 $39,115 - $61,218
1,074 Added 9.2%
12,748 $526,000
Q2 2020

Aug 05, 2020
SELL
$39.26 - $52.73 $62,894 - $84,473
-1,602 Reduced 12.07%
11,674 $566,000
Q1 2020

May 14, 2020
SELL
$31.65 - $46.87 $35,448 - $52,494
-1,120 Reduced 7.78%
13,276 $561,000
Q4 2019

Feb 13, 2020
SELL
$36.21 - $51.4 $512,987 - $728,183
-14,167 Reduced 49.6%
14,396 $616,000
Q3 2019

Nov 12, 2019
SELL
$22.22 - $44.01 $106,744 - $211,424
-4,804 Reduced 14.4%
28,563 $1.03 Million
Q2 2019

Aug 13, 2019
BUY
$23.32 - $28.12 $778,118 - $938,280
33,367 New
33,367 $892,000

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email